“ THIENO-
Application 422/DELNP/2004 published 2006-03-10, filed 2004-02-23
The use of a compound comprising formula (I), or a salt, ester, amide or prodrug thereof in the treatment of obesity and related disorders. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them. In formula (I): A is an optionally substituted thienyl moiety, Y is O, S, or NR2, R1 is a branched or unbranched alkyl (optionally interrupted by one or more oxygen atoms), alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl or a substituted derivative of any of the foregoing groups and R2 is hydrogen or a group as defined for R1.
Applicant
ALIZYME THERAPEUTICS LIMITED
Granta Park, Great Abington, Cambridgeshire CB1 6GX, Great Britain
Inventor
1. HODSON, Harold, Francis 2. DUNK, Christopher, Robert 3. PALMER, Richard, Michael, John 4. MITCHELL, Dale, Robert 5. BIRAULT, Veronique 6. HUNT, Russell, George
International Info
Classification: A61K 31/535
Publication Number: WO 03/020282
Application Date: 2002-08-23
Priority Information
0121019.4 Great Britain 2001-08-30
0206031.7 Great Britain 2002-03-14